OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder
- Conditions
- Attention Deficit DisorderAttention Deficit Hyperactivity Disorder
- Interventions
- Other: Placebo
- First Posted Date
- 2018-07-30
- Last Posted Date
- 2021-10-18
- Target Recruit Count
- 590
- Registration Number
- NCT03605836
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, Orlando, Florida, United States
A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2023-11-14
- Target Recruit Count
- 259
- Registration Number
- NCT03594123
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, Miami, Florida, United States
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
- Conditions
- SchizophreniaSchizoaffective DisorderFirst Episode Psychosis
- Interventions
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2020-07-16
- Target Recruit Count
- 44
- Registration Number
- NCT03568500
- Locations
- 🇬🇧
Clinical Trial Site, Southampton, United Kingdom
A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type
- Conditions
- Agitation Associated With Alzheimer's DementiaAlzheimer Dementia
- Interventions
- Other: Placebo
- First Posted Date
- 2018-06-07
- Last Posted Date
- 2023-09-18
- Target Recruit Count
- 345
- Registration Number
- NCT03548584
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, Los Angeles, California, United States
A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: Antidepressant therapy
- First Posted Date
- 2018-05-29
- Last Posted Date
- 2023-10-12
- Target Recruit Count
- 1149
- Registration Number
- NCT03538691
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, Los Angeles, California, United States
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2022-05-24
- Target Recruit Count
- 10
- Registration Number
- NCT03420222
- Locations
- 🇺🇸
Sarkis Clinical Trials, Gainesville, Florida, United States
🇺🇸Atlanta Center for Medical Research, Atlanta, Georgia, United States
🇺🇸University of Chicago Medical Center Clinical Trial Site 2, Chicago, Illinois, United States
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
- Conditions
- Agitation in Patients With Dementia of the Alzheimer's Type
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-01-08
- Last Posted Date
- 2024-11-20
- Target Recruit Count
- 601
- Registration Number
- NCT03393520
- Locations
- 🇺🇸
Advanced Research Center, Inc #835, Anaheim, California, United States
🇺🇸ATP Clinical Research, Inc #763, Costa Mesa, California, United States
🇺🇸Crystal Biomedical Research, LLC, Miami Lakes, Florida, United States
The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder
- Conditions
- Adult Attention Deficit Hyperactivity Disorder
- Interventions
- First Posted Date
- 2017-10-27
- Last Posted Date
- 2021-10-29
- Target Recruit Count
- 239
- Registration Number
- NCT03324581
- Locations
- 🇺🇸
iResearch Atlanta, Decatur, Georgia, United States
🇺🇸Premier Psychiatric Research Institute, LLC, Lincoln, Nebraska, United States
🇺🇸Psychiatric Associates, Overland Park, Kansas, United States
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
- Conditions
- Bipolar I DisorderADHDAutismConduct DisorderOppositional Defiant Disorder
- Interventions
- First Posted Date
- 2017-09-26
- Last Posted Date
- 2018-06-12
- Target Recruit Count
- 24
- Registration Number
- NCT03292848
- Locations
- 🇺🇸
Woodland Research Northwest, LLC, Rogers, Arkansas, United States
🇺🇸Alliance for Wellness dba Alliance for Research, Long Beach, California, United States
🇺🇸Cutting Edge Research Group, Oklahoma City, Oklahoma, United States
A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.
- First Posted Date
- 2017-09-19
- Last Posted Date
- 2020-08-17
- Target Recruit Count
- 381
- Registration Number
- NCT03287869
- Locations
- 🇺🇸
Woodland Research Northwest, LLC, Rogers, Arkansas, United States
🇧🇬"Mental Health Centre-Ruse" EOOD, Male department for persons with severe mental disorders, Female department for persons with severe mental disorders, Ruse, Bulgaria
🇵🇱Indywidualna Specjalistyczna Praktyka Lekarska Wieslaw Jerzy Cubala, Gdańsk, Poland